These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33467114)

  • 21. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
    Liu WY; Zheng KI; Pan XY; Ma HL; Zhu PW; Wu XX; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1057-1064. PubMed ID: 31677195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients.
    Borman MA; Ladak F; Crotty P; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Duarte-Rojo A; Elkashab M; Myers RP
    Hepatol Int; 2013 Jun; 7(2):592-9. PubMed ID: 26201792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population.
    Takahashi S; Tanaka M; Higashiura Y; Mori K; Hanawa N; Ohnishi H; Furuhashi M
    Endocr J; 2022 Apr; 69(4):463-471. PubMed ID: 34803123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
    Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.
    Wang J; Xu C; Xun Y; Lu Z; Shi J; Yu C; Li Y
    Sci Rep; 2015 Nov; 5():16494. PubMed ID: 26568423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population.
    Khani V; Momeni Moghaddam A; Hatami B
    Gastroenterol Hepatol Bed Bench; 2022; 15(4):360-365. PubMed ID: 36762218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
    Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
    Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
    United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
    Siddiqui MS; Vuppalanchi R; Van Natta ML; Hallinan E; Kowdley KV; Abdelmalek M; Neuschwander-Tetri BA; Loomba R; Dasarathy S; Brandman D; Doo E; Tonascia JA; Kleiner DE; Chalasani N; Sanyal AJ;
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):156-163.e2. PubMed ID: 29705261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
    Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
    World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
    Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
    Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.
    Yu SJ; Kim DH; Lee JH; Chung GE; Yim JY; Park MJ; Kim YJ; Yoon JH; Jang JJ; Lee HS
    Korean J Gastroenterol; 2011 Jan; 57(1):19-27. PubMed ID: 21258197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
    Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
    Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.